BANK OF AMERICA CORP /DE/ - ANNOVIS BIO INC ownership

ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 25 filers reported holding ANNOVIS BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ANNOVIS BIO INC
ValueSharesWeighting
Q3 2023$1,680
-33.6%
1770.0%0.00%
Q2 2023$2,529
-82.5%
177
-83.5%
0.00%
Q4 2022$14,423
-46.6%
1,074
-46.1%
0.00%
Q3 2022$27,000
-72.7%
1,991
-77.0%
0.00%
Q2 2022$99,000
+3.1%
8,662
+20.8%
0.00%
Q1 2022$96,000
-55.1%
7,168
-41.0%
0.00%
Q4 2021$214,000
-61.4%
12,151
-30.5%
0.00%
Q3 2021$555,00017,478
+124742.9%
0.00%
Q1 2021$0
-100.0%
14
-98.9%
0.00%
Q1 2020$4,0001,2250.00%
Other shareholders
ANNOVIS BIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 48,941$464,4500.22%
Redmond Asset Management, LLC 34,080$323,4190.12%
Sterling Investment Advisors, Ltd. 34,374$326,2090.11%
Wescott Financial Advisory Group, LLC 41,607$394,8500.07%
Worth Venture Partners, LLC 12,321$116,9260.07%
Koshinski Asset Management, Inc. 15,000$142,3500.02%
Merit Financial Group, LLC 41,200$390,9880.01%
FNY Investment Advisers, LLC 1,133$100.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 300,000$2,847,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 23,600$223,9640.01%
View complete list of ANNOVIS BIO INC shareholders